Why Is the FDA Expediting an RSV mRNA Vaccine?

Oh, boy, here we go again! Is a respiratory syncytial virus (RSV) mRNA vaccine something that really needs to be fast-tracked? Why can’t the FDA follow its normal vaccine safety process for mRNA ‘vaccine’ evaluations? This smells of regulatory capture. This wreaks of vaccine companies rushing to promote a “new” and under-evaluated medical technology to capitalize on a wave of industry promoted fear related to Covid. As Dr. Joseph Mercola points out in his article FDA Fast-Tracks RSV mRNA ‘Vaccine’,

The rollout of mRNA COVID shots have, as predicted, paved the way for any number of new mRNA-based injections going straight to human trials. So, should you ever feel like your body lacks in synthetic mRNA, fear not. This is just the beginning. Those who embrace vaccine passports will surely find themselves called to the nearest vaccine center several times a year for mandatory refills.

Analysis by Dr. Joseph Mercola